5.380USD+4.87%Mkt Cap: 160.26M USDP/E: —Last update: 2026-05-26
Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic thro…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
105.81BDKKP/E 20.4
66.47BUSDP/E 15.5
46.56BEURP/E 30.5
43.89BEURP/E 36.5
39.41BUSDP/E 74.0
32.84BUSD—
32.05BSEKP/E 47.4
Indicators:|
Key Statistics
Company
Market Cap160.26M USD
Enterprise Value142.83M USD
Revenue (TTM)—
Gross Profit-974.60K USD
Net Income (TTM)-3.84M USD
Revenue/Share—
Last Price5.380 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees2
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-33.13
PEG—
EV/EBITDA-18.70
EV/Revenue—
P/S—
P/B276.11
EPS (TTM)-0.13
EPS (Forward)-0.15
52W Range
2.57012% of range26.50
52W High26.50 USD
52W Low2.570 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-129.17%
ROA—
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.36M USD
CapEx (TTM)99.47K USD
FCF Margin—
FCF Yield—
Net Debt-5.21M USD
Net Debt/EBITDA0.68
Balance Sheet
Debt/Equity-0.68
Current Ratio2.23
Quick Ratio2.19
Book Value/Sh0.0180 USD
Cash/Share0.3770 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)8.000 USD
Target Range8.000 USD – 8.000 USD
# Analysts1
Ownership
Shares Out.29.79M
Float11.13M
Insiders63.74%
Institutions1.74%
Short Interest
Short Ratio1.9d
Short % Out.0.17%
Shares Short60.22K
Short (prev mo.)63.13K
Technical
SMA 503.644 (+47.6%)
SMA 2003.958 (+35.9%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)32.31K
Avg Vol (10d)50.14K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—